THE BOTTOM LINE
Since October 30, 2026, HHS says it won't take enforcement action against licensed 503A pharmacies and physicians that compound Semax free base for intranasal use under its conditions. Injectable Semax and Semax combination sprays are not covered. Semax is not FDA approved in the US, and its human evidence comes mainly from small studies of nasal use.
SIDE-BY-SIDE
What actually differs
What changed on October 28
Semax is one of six peptides in HHS's October 28, 2026 enforcement discretion policy. Starting October 30, HHS says it does not intend to act against covered compounders that make Semax free base for intranasal use under the policy's conditions.
FDA's advisory committee recommended Semax for the 503A Bulks List on July 24, 2026. It was nominated for neurologic uses such as cerebral ischemia, migraine and trigeminal neuralgia.
The policy's other conditions apply to every one of the six peptides: the ingredient must come from an FDA-registered facility with a valid certificate of analysis made under CGMP, the product may contain only one active ingredient, the only delivery device allowed is an FDA 510(k)-cleared syringe, the label must say it is a compounded drug not for resale, and serious adverse events must be reported to FDA MedWatch.
What it didn't change
It did not approve the peptide; compounded drugs are not FDA approved. It did not add it to the 503A Bulks List, which still requires formal rulemaking. It does not cover "research use only" vials, blends with other peptides, or any route the policy doesn't list. HHS calls the policy interim and says it can revisit it; public comments are open through November 13, 2026.
The route limit is the big one for Semax: nasal only. The policy's device rule names a 510(k)-cleared syringe and doesn't mention spray pumps, so ask exactly how a nasal product is dispensed.
What Semax is, and what the evidence says
Semax is a synthetic peptide derived from a fragment of ACTH, studied mainly for neurological effects. It's used in Russia, where most of its clinical research was done, typically as nasal drops.
The human studies are small and largely from one country. Focus, memory and "nootropic" claims in healthy people are not established. Injectable Semax sold online has essentially no human record behind it.
Who should slow down
Anyone with a seizure disorder, a psychiatric condition or on medications that act on the brain should talk to a clinician first. Anyone pregnant or breastfeeding. Athletes in tested sport should check the WADA list.
Ask any provider: Is a licensed clinician reviewing my case? Which state-licensed 503A pharmacy fills it? Is there a certificate of analysis for the ingredient? Is it this peptide alone, with no blend? Is the route one the policy covers? What's the full price, including refills, and how do I cancel? If anything says "FDA approved," treat that as a red flag.
QUICK ANSWERS
Is Semax legal now?
Since October 30, 2026, licensed 503A pharmacies and physicians can compound Semax free base for intranasal use without federal enforcement, if they meet the HHS policy conditions. Injectable Semax is not covered, and Semax is not FDA approved.
Is injectable Semax covered?
No. The policy covers intranasal Semax only.
PRIMARY & AUTHORITATIVE SOURCES
Check the underlying record
Regulatory status and labeling can change. Sources were reviewed on the article update date; current prescribing information controls.COMPARE THE CARE MODEL
Medication is only one part of the decision.
Use the 30-second filter to identify the costs, clinical safeguards and service terms worth checking before you enroll.
Find my starting point →